flgt-corresp.DOCX.htm

 

FULGENT GENETICS, iNC.

4978 Santa Anita Avenue

Temple City, CA 91780

 

 

August 7, 2020

 

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:  Jeffrey Gabor

 

RE:

Fulgent Genetics, Inc.

 

Registration Statement on Form S-3

 

Filed July 21, 2020, as amended on August 5, 2020

 

File No. 333-239964

 

Request for Acceleration

 

Ladies and Gentlemen:

 

With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Fulgent Genetics, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to August 12, 2020, at 8:55 a.m. Eastern Time, or as soon as is practicable thereafter.

 

The cooperation of the staff in meeting the timetable described above is very much appreciated.

 

Please call Melanie Ruthrauff Levy of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (858) 314-1873, with any comments or questions regarding the Registration Statement.

 

Very truly yours,

 

FULGENT GENETICS, Inc.

 

 

/s/ Paul Kim

Paul Kim

Chief Financial Officer

 

 

cc:

Melanie Ruthrauff Levy, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.